Alba Toll

609 total citations
29 papers, 246 citations indexed

About

Alba Toll is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Alba Toll has authored 29 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 6 papers in Pharmacology. Recurrent topics in Alba Toll's work include Schizophrenia research and treatment (11 papers), Bipolar Disorder and Treatment (10 papers) and Tryptophan and brain disorders (4 papers). Alba Toll is often cited by papers focused on Schizophrenia research and treatment (11 papers), Bipolar Disorder and Treatment (10 papers) and Tryptophan and brain disorders (4 papers). Alba Toll collaborates with scholars based in Spain, United Kingdom and United States. Alba Toll's co-authors include Víctor Pérez, Anna Mané, Daniel Bergé, Laura Díaz, Miquel Bernardo, Rosa Ayesa‐Arriola, Emilio Fernández-Egea, Esther Setién‐Suero, Benedicto Crespo‐Facorro and Gisela Mezquida and has published in prestigious journals such as Psychological Medicine, Journal of Affective Disorders and Psychoneuroendocrinology.

In The Last Decade

Alba Toll

27 papers receiving 244 citations

Peers

Alba Toll
Comparison fields: 5 of 50
  • Psychiatry and Mental health 128
  • Clinical Psychology 70
  • Pharmacology 63
  • Biological Psychiatry 50
  • Cellular and Molecular Neuroscience 36
Thomas Charpeaud France
N. Del Cacho Spain
Keane Lim Singapore
Mehak Pahwa United States
Dorte Nordholm Denmark
Christian Núñez Spain
María Juncal‐Ruíz Spain
Yuen Mei See Singapore
Mercedes Zumárraga Spain
Matteo Lazzaretti Italy
Thomas Charpeaud France View profile →
Citations per field, relative to Alba Toll
Alba Toll · 1×
Citations per year, relative to Alba Toll
Alba Toll · 1×

Countries citing papers authored by Alba Toll

Since Specialization
Citations

This map shows the geographic impact of Alba Toll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Toll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Toll more than expected).

Fields of papers citing papers by Alba Toll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Toll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Toll. The network helps show where Alba Toll may publish in the future.

Co-authorship network of co-authors of Alba Toll

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Toll. A scholar is included among the top collaborators of Alba Toll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Toll. Alba Toll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Clozapine use in the first two years after first-episode psychosis in a real-world clinical sample PubMed Alba Toll, Daniel Bergé et al. 1
2 Relationship between thyroid-stimulating hormone, BDNF levels, and hippocampal volume in antipsychotic-naïve first-episode psychosis patients Frontiers in Psychiatry Alba Toll, Laura Blanco‐Hinojo et al. 6
3 Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug–na ïve first-episode psychosis European Neuropsychopharmacology Alba Toll, Laura Blanco‐Hinojo et al. 3
4 Y-chromosome in the olfactory neuroepithelium as a potential biomarker of depression in women with male offspring: an exploratory study Molecular and Cellular Biochemistry Pilar Álvarez, Beatríz Bellosillo et al. 1
5 Factors associated with suicide attempts in first-episode psychosis during the first two years after onset Psychiatry Research Alba Toll, Daniel Bergé et al. 10
6 Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning Progress in Neuro-Psychopharmacology and Biological Psychiatry Alejandro de la Torre‐Luque, Neus Salvat‐Pujol et al. 13
7 Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode Psychological Medicine Gisela Mezquida, Patricia Gassó et al. 7
8 Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females Frontiers in Psychiatry Sílvia Amoretti, Norma Verdolini et al. 2
9 Relationship between immunometabolic status and cognitive performance among major depression disorder patients Psychoneuroendocrinology Alejandro de la Torre‐Luque, Marı́a J. Portella et al. 2
10 Determinants of mechanical restraint in an acute psychiatric care unit World Journal of Psychiatry Antonio R. Moreno‐Poyato, Alba Toll et al. 7
11 Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis Schizophrenia Research Leticia González-Blanco, María Paz García‐Portilla et al. 7
12 A multicenter, observational study of pain and functional impairment in individuals with major depressive disorder in partial remission: the DESIRE study Journal of Affective Disorders Víctor Pérez, Adrián Pérez‐Aranda et al. 4
13 Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosis European Archives of Psychiatry and Clinical Neuroscience Alba Toll, Daniel Bergé et al. 7
14 Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder Journal of Affective Disorders Marı́a J. Portella, Neus Salvat‐Pujol et al. 15
15 The Suicide Prevention and Intervention Study (SURVIVE): Study protocol for a multisite cohort study with nested randomized-controlled trials PubMed Víctor Pérez, Matilde Elices et al. 5
16 Targeting recovery in first episode psychosis: The importance of neurocognition and premorbid adjustment in a 3-year longitudinal study Schizophrenia Research Esther Setién‐Suero, Alba Toll et al. 20
17 Inverse association between negative symptoms and body mass index in chronic schizophrenia Schizophrenia Research Gisela Mezquida, George Savulich et al. 21
18 Brain-derived neurotrophic factor levels in first episode of psychosis: A systematic review World Journal of Psychiatry Alba Toll 37
19 Relationship between cannabis and psychosis: Reasons for use and associated clinical variables Psychiatry Research Anna Mané, Daniel Bergé et al. 43
20 The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study International Journal of Clinical Practice Kerstin Fugl-Meyer, Diane R. Stothard et al. 17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026